Dáil Éireann Debate, Tuesday - 3 November 2020
128. Deputy Rose Conway-Walsh asked the Minister for Health if his attention has been drawn to a report (details supplied) and developments in France regarding the prescribing of epilim, also known as valproate, to pregnant mothers; his plans to progress the issue here; and if he will make a statement on the matter. [33531/20]
View answerThe issues and risks associated with the use of sodium valproate by women of childbearing age are well recognised by medicines regulators and healthcare professionals in Ireland. I am aware of the recent publication of the Independent Medicines and Medical Devices Safety Review in the UK, and of the French Government’s compensation scheme, and I have agreed to meet relevant patient groups later this month to discuss a range of issues relating to sodium valproate.
